David Gilligan

University of Cambridge — United Kingdom

Medicine · Health Sciences

48h-index8.6kcitations234works4.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(53), Lung Cancer Diagnosis and Treatment(47), Cardiac Arrhythmias and Treatments(35), Cardiac pacing and defibrillation studies(26), Cardiac electrophysiology and arrhythmias(20)

Publications227 total

205 A clinical practice guide to post-operative radiotherapy for Thymic Epithelial Tumours
Lung Cancer·2026
Defining the Clinical Target Volume in Postoperative Thymic Epithelial Tumours - A Clinical Practice Guide for UK Clinical Oncologists
Clinical Oncology·2025Open Access
Abstract 7147: Ultra-high throughput single-nuclei RNAs sequencing of malignant pleural mesothelioma samples in the BEAT-MESO clinical trial
Cancer Research·2025
A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer
npj Precision Oncology·2025· 3 citedOpen Access
Lung cancer: three priorities for improved survival rates
British Journal of Healthcare Management·2024
74 Is Age A Thing? Accessing Treatment for Pleural Mesothelioma
Lung Cancer·2024
84 National Real World Study of Adjuvant Osimertinib in Resected EGFR Mutated Lung Cancer
Lung Cancer·2024
11 Making an accurate diagnosis of anterior mediastinal lesions: A proposal for a new diagnostic algorithm from the BTOG Thymic Interest Group
Lung Cancer·2024· 1 cited
26 Implementation of a neoadjuvant lung cancer treatment pathway in a regional tertiary centre
Lung Cancer·2024
Making an accurate diagnosis of anterior mediastinal lesions: a proposal for a new diagnostic algorithm from the BTOG Thymic Malignancies Special Interest Group
Clinical Radiology·2024· 4 citedOpen Access
Atrial fibrillation symptom reduction and improved quality of life following the hybrid convergent procedure: a CONVERGE trial subanalysis
Annals of Cardiothoracic Surgery·2024· 3 citedOpen Access
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma
JAMA Oncology·2024· 40 citedOpen Access
Abstract A115: mTOR targeting in STK11 deficient Non-Small Cell Lung Cancer (NSCLC): final results, pre-clinical rationale and biomarker analysis of a phase II trial of the mTORC1/2 inhibitor vistusertib in STK11 deficient lung adenocarcinoma (NLMT B2)
Molecular Cancer Therapeutics·2023· 1 cited
MA06.06 A Phase II Trial of Ceralasertib and Durvalumab in Advanced Non-Small Cell Lung Cancer (NSCLC) with and without RAS Mutations: Results of NLMT Arm J
Journal of Thoracic Oncology·2023Open Access
Thymic epithelial tumour radiotherapy in the UK: A survey of current clinical practice
Radiotherapy and Oncology·2023· 2 citedOpen Access
PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma
Journal for ImmunoTherapy of Cancer·2023· 11 citedOpen Access
PO-02-168 ONE-YEAR OUTCOMES OF PULMONARY VEIN ISOLATION WITH A NOVEL CRYOBALLOON IN 325 PATIENTS: PRIMARY RESULTS OF THE FROZEN AF TRIAL
Heart Rhythm·2023· 1 citedOpen Access
PD-0162 Thymic epithelial tumour radiotherapy: A survey of current UK clinical practice
Radiotherapy and Oncology·2023
A case of malignant mesothelioma in a young patient with childhood leukaemia who had received total body irradiation
Oxford Medical Case Reports·2023· 2 citedOpen Access
Abstract CT007: Phase 2-3 trial of pegargiminase plus chemotherapy versus placebo plus chemotherapy in patients with non-epithelioid pleural mesothelioma
Cancer Research·2023· 8 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Kenneth A. Ellenbogen(8), Julio A. Panza(7), Arshed A. Quyyumi(7), Carlos A. Morillo(6), Mark A. Wood(5), R O Cannon(4), Nader Dakak(4), Richard O. Cannon(4), James Spicer(4), M. Hatton(3), Jan P. van Meerbeeck(3), Richard Stephens(3), Sanjay Popat(3), Robin Rudd(3), Allan Hackshaw(3), Robert S. Sheldon(3), Satish R. Raj(3), Andrew D. Krahn(3), Eduardo Medina(3), Mark A. Wood(3)